US Patent 11014991 Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody
Patent 11014991 was granted and assigned to Apogenix on May, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11014991 Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.